VNDA - バンダ・ファ―マシュ―ティカルズ （Vanda Pharmaceuticals Inc.）

Vanda Pharmaceuticals has fallen largely due to legal setbacks around its primary approved drug HETLIOZ. Find out why VNDA stock is a Hold.

WASHINGTON, June 5, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2023 Global Healthcare Conference in New York City on Friday, June 9, 2023. A corporate presentation is scheduled for 12:15 p.m….

Mirae Asset Global Investments Co. Ltd. boosted its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 13.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,592 shares of the biopharmaceutical company’s stock after purchasing an additional 3,374 shares […]

… Funds Weigh In On Vanda Pharmaceuticals Several institutional investors and … institutional investors. About Vanda Pharmaceuticals (Get Rating) Vanda Pharmaceuticals , Inc engages in … '' ratings for Vanda Pharmaceuticals and related companies with MarketBeat …

Vanda Pharmaceuticals Inc. (NASDAQ:NASDAQ:VNDA) Q1 2023 Earnings Conference Call May 3, 2023 4:30 AM ETCompany ParticipantsKevin Moran - CFOMihael Polymeropoulos - President, CEO and…

The company had sued federal regulators as part of its yearslong quest to bring a jet lag treatment to market.

A judge has ruled that Vanda Pharmaceuticals should have access to documents related the the FDA''s review of a supplemental jet lag indication for Hetlioz. Read more.

Joakim Wijkstrom , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Wijkstrom sold 11,833 shares of Vanda Pharma . The total transaction amounted to $74,116. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com

Kevin Patrick Moran , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Moran sold 13,934 shares of Vanda Pharma . The total transaction amounted to $87,344. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com

Gunther Birznieks , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Birznieks sold 16,777 shares of Vanda Pharma . The total transaction amounted to $104,583. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com

The company had sued federal regulators as part of its yearslong quest to bring a jet lag treatment to market.

A judge has ruled that Vanda Pharmaceuticals should have access to documents related the the FDA''s review of a supplemental jet lag indication for Hetlioz. Read more.

Joakim Wijkstrom , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Wijkstrom sold 11,833 shares of Vanda Pharma . The total transaction amounted to $74,116. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com

Kevin Patrick Moran , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Moran sold 13,934 shares of Vanda Pharma . The total transaction amounted to $87,344. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com

Gunther Birznieks , SVP at Vanda Pharma (NASDAQ: VNDA ), reported a large insider sell on March 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Birznieks sold 16,777 shares of Vanda Pharma . The total transaction amounted to $104,583. Vanda Pharma shares are trading up 0.08% at $6.33 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com